innovation for industry
Article | Micro-nanoelectronics
A unique interface between patients and the medical industry
Hub4aim has an unique proposal to manage the preindustrial
phase from the proof of concept to regulatory marking.
Iprasense's new Cytonote Counter does more than let you observe cells in culture-it assesses cell viability, providing unparalleled precision and reproducibility.
Although it is already used to treat certain skin cancers, photodynamic therapy cannot reach the deepest lesions. The micro needle patch patented by CEA-Leti and Inserm* overcomes this limitation. It could reach the market in 3 to 5 years.
Terradona* sells a connected deposit-inspired solution for recycling drop-off containers that is gradually gaining traction. When equipped with the company’s smart panel, containers can actually encourage users to sort better.
GRENOBLE, France – October 7th, 2019 – For the first time, a tetraplegic patient was able to walk and control both arms using this neuroprosthetic, which records, transmits, and decodes brain signals in real-time to control an exoskeleton. The results of a clinical study under the Brain Computer Interface (BCI) Project at Clinatec were published on 4 October 2019 in The Lancet Neurology journal and provide proof of concept for controlling a four-limb exoskeleton. The system is driven via the long-term implant of a semi-invasive medical device to record brain activity developed at CEA in Grenoble. In the long term, this technology is expected to give greater mobility to individuals with severe motor disabilities.
Nano-biotechnology PlatformClinatec Platform
Connected Health ＆ WellnessAgriculture, Food Industry ＆ Environment
Smart Medical Technologies
See all demos
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.